Friedrich Fitz

The Use of F-18 Choline PET in the Assessment of Bone Metastases in Prostate Cancer: Correlation with Morphological Changes on CT (vol 11, pg 446, 2009)

Erratum to: The Use of F-18 Choline PET in the Assessment of Bone Metastases in Prostate Cancer: Correlation with Morphological Changes on CT Mohsen Beheshti, Reza Vali, Peter Waldenberger, Friedrich Fitz, Michael Nader, Josef Hammer, Wolfgang Loidl, Christian Pirich, Ignac Fogelman, Werner Langsteger Nuclear Medicine & Endocrinology, PET/CT Center Linz, St. Vincent’s Hospital, Linz, Austria Radiology, St. Vincent’s Hospital, Linz, Austria Radiation Oncology, St. Vincent’s Hospital, Linz, Austria Urology, St. Vincent’s Hospital, Linz, Austria Nuclear Medicine & Endocrinology, Paracelsus Private Medical University, Salzburg, Austria Division of Imaging, King’s College, London, UK

68Ga-PSMA PET/CT with MRI fusion: spinal cord metastasis from prostate cancer

Metastatic prostate cancer is the second most common cause of spinal cord compression. However, to the best of our knowledge, direct metastatic spread to the spinal cord has not been reported in the medical literature so far. Ga-PSMA PET/CT was performed in a 72-year-old patient with prostate cancer (Gleason score 9, PSA level at diagnosis 30.6 ng/mL) after radical prostatectomy with evidence of biochemical recurrence (trigger PSA level